Related Experiment Videos
The case for bar coding: better information, better care--and better business
Healthcare Executive
|September 25, 2003
Summary
Healthcare providers are adopting bar coding technology for prescription drugs. A new FDA rule mandates unit dose bar coding by mid-2004, improving drug identification and safety.
Area of Science:
- Health Informatics
- Regulatory Science
- Pharmaceutical Technology
Background:
- Bar coding adoption in healthcare has lagged due to system fragmentation, lack of standards, and limited market incentives.
- Previous barriers included disparate systems, absence of standardization, and insufficient market incentives for healthcare providers, IT vendors, and drug manufacturers.
Purpose of the Study:
- To highlight the impending regulatory changes driving bar code adoption in the pharmaceutical industry.
- To inform stakeholders about the U.S. Food and Drug Administration's (FDA) proposed rule mandating unit dose bar coding for prescription drugs.
Main Methods:
- Analysis of a proposed FDA rule mandating bar code implementation.
- Review of factors hindering and promoting bar code technology adoption in healthcare.
Main Results:
- A proposed FDA rule is expected to be finalized by mid-2004, requiring all drugmakers to implement unit dose level bar coding for prescription drug products.
- The mandated bar codes will uniquely identify the drug, manufacturer, strength, and dosage of medications.
Conclusions:
- The upcoming FDA regulation is a significant catalyst for the widespread adoption of bar code technology in the pharmaceutical sector.
- Mandatory unit dose bar coding is poised to enhance drug safety and traceability within the healthcare system.